|
3356
|
AMG 9810
|
Potent and selective vanilloid receptor-1 (TRPV1) antagonist |
€90.00 |
|
3363
|
Azilsartan
|
Potent AT1 antagonist |
€60.00 |
|
3357
|
BAMB-4
|
Membrane permeable ITPKA inhibitor (InsP3Kinase specific) |
€120.00 |
|
3360
|
CBS1117
|
Virus entry inhibitor |
€110.00 |
|
3358
|
CTPI-2
|
Specific SLC25A1 inhibitor |
€60.00 |
|
3216
|
DCZ0415
|
AAA-ATPase TRIP13 inhibitor |
€85.00 |
|
3367
|
Empagliflozin
|
Potent and selective SGLT2 inhibitor |
€80.00 |
|
3370
|
Irinotecan hydrochloride
|
Prodrug of SN-38; Topoisomerase I (Topo 1) inhibitor |
€80.00 |
|
3404
|
LY-364947
|
Potent, selective and ATP-competitive TGF-βR 1 inhibitor |
€90.00 |
|
3319
|
Methotrexate
|
Potent, competitive inhibitor of dihydrofolate reductase |
€60.00 |
|
3364
|
Naproxen sodium
|
COX-inhibitor; NSAID |
€40.00 |
|
3374
|
Nepafenac
|
Prodrug of Amfenac; COX-inhibitor |
€50.00 |
|
3368
|
Podophyllotoxin
|
Tubulin polymerization inhibitor |
€40.00 |
|
3177
|
Primaquine diphosphate
|
Transmission-blocking anti-malarial drug |
€50.00 |
|
3365
|
Repaglinide
|
K+ channel blocker (SUR1/Kir6.2 selective) |
€90.00 |
|
3372
|
Rifabutin
|
Potent broad-spectrum antibiotic |
€80.00 |
|
3376
|
Rofecoxib
|
Orally active COX-2 inhibitor |
€60.00 |
|
3359
|
URB937
|
Potent, orally available, and peripherally restricted FAAH inhibitor |
€80.00 |
|
3362
|
Vistonuridine
|
Uridine prodrug |
€50.00 |
|
3382
|
Zidovudine
|
NRT inhibitor |
€50.00 |